The sales revenue of the BioTechUSA company group increased by 40 percent last year
The BioTechUSA company group closed the year 2022 with a record financial result, its sales revenue increased by 41 percent and reached HUF 80.4 billion, its earnings before interest, taxes and depreciation (EBITDA) increased from HUF 9.2 billion to HUF 11.5 billion.
The Hungarian family-owned group of companies expanded its portfolio with 300 new products, opened 17 new stores and launched the largest investment in its history in 2022, which will continue this year – explained Bálint Lévai, CEO and co-owner of BioTechUSA Kft., at the press conference presenting the company’s annual results.
About 80 percent of the total sales revenue of one of the largest food supplement and specialty food manufacturing and distribution groups in Europe last year came from exports, and the international store network produced a 216 percent increase in turnover.
Related news
A maternity ward diary, a healing garden, and a trauma-informed adult education system are among this year’s BioTechUSA for Health Award winners
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >The momentum of the Hungarian marketing industry is slowing: profits are falling, costs are rising
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >Waberer’s Group’s sales and after-tax profit both increased in the third quarter
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >Related news
Shared thinking, conscious renewal: the Hungarian retail real estate market has reached a turning point
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >Holiday opening hours at PENNY
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >Lidl: another special tax increase could lead to chain closures in the Hungarian market
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >
